lapatinib has been researched along with sofosbuvir in 1 studies
Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (sofosbuvir) | Trials (sofosbuvir) | Recent Studies (post-2010) (sofosbuvir) |
---|---|---|---|---|---|
1,919 | 305 | 1,442 | 2,164 | 318 | 2,064 |
Protein | Taxonomy | lapatinib (IC50) | sofosbuvir (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 8.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kassem, H; Kassem, N; Talima, S | 1 |
1 other study(ies) available for lapatinib and sofosbuvir
Article | Year |
---|---|
Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Breast Neoplasms; Breast Neoplasms, Male; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lapatinib; Liver; Male; Middle Aged; Retrospective Studies; Sofosbuvir; Trastuzumab; Virus Replication | 2019 |